文献速递其他结缔组织病血管炎

系统性硬化症中血小板经PSGL-1吞噬清除缺陷与微粒蓄积

Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2021-12-23

OBJECTIVE: It is unclear why activated platelets and platelet-derived microparticles (MPs) accumulate in the blood of patients with systemic sclerosis (SSc).…

要点

  • SSc患者中性粒细胞PSGL-1表达显著降低,活化血小板未被吞噬清除。
  • SSc患者血中P-选择素+血小板及HMGB1+ MPs蓄积,健康对照无此现象。
  • HMGB1+ MPs诱导NET生成,NET仅见于SSc患者血浆。

核心结论

  • 经PSGL-1清除活化血小板可限制MP诱导的中性粒细胞活化不良效应,该平衡在SSc患者中被破坏,重建此平衡或可抑制血管炎症并预防纤维化。

主要发现

  • 活化P-选择素+血小板及血小板来源HMGB1+ MPs在SSc患者血中蓄积,健康对照血中未蓄积。
  • 不依赖系统性炎症的血管病CAD患者P-选择素+血小板较少,MPs数量可忽略。
  • SSc患者中性粒细胞PSGL-1表达显著降低,活化血小板未在中性粒细胞中检出,而CAD患者中性粒细胞中持续存在。
  • HMGB1+ MPs诱导NET生成,NET仅见于SSc患者血浆。
  • 小鼠中P-选择素-PSGL-1相互作用在体外导致血小板吞噬,并影响MPs诱导NET、内皮活化及白细胞经肺微血管迁移的能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It is unclear why activated platelets and platelet-derived microparticles (MPs) accumulate in the blood of patients with systemic sclerosis (SSc). This study was undertaken to investigate whether defective phagocytosis might contribute to MP accumulation in the blood of patients with SSc. METHODS: Blood samples were obtained from a total of 81 subjects, including 25 patients with SSc and 26 patients with stable coronary artery disease (CAD). Thirty sex- and age-matched healthy volunteers served as controls. Studies were also conducted in NSG mice, in which the tail vein of the mice was injected with MPs, and samples of the lung parenchyma were obtained for analysis of the pulmonary microvasculature. Tissue samples from human subjects and from mice were assessed by flow cytometry and immunochemical analyses for determination of platelet-neutrophil interactions, phagocytosis, levels and distribution of P-selectin, P-selectin glycoprotein ligand 1 (PSGL-1), and HMGB1 on platelets and MPs, and concentration of byproducts of neutrophil extracellular trap (NET) generation/catabolism. RESULTS: Activated P-selectin+ platelets and platelet-derived HMGB1+ MPs accumulated in the blood of SSc patients but not in the blood of healthy controls. Patients with CAD, a vasculopathy independent of systemic inflammation, had fewer P-selectin+ platelets and a negligible number of MPs. The expression of the receptor for P-selectin, PSGL-1, in neutrophils from SSc patients was significantly decreased, raising the possibility that phagocytes in SSc do not recognize activated platelets, leading to a failure of phagocytosis and continued neutrophil release of MPs. As evidence of this process, activated platelets were not detected in the neutrophils from SSc patients, whereas they were consistently present in the neutrophils from patients with CAD. HMGB1+ MPs elicited generation of NETs, which were only detected in the plasma of SSc patients. In mice, P-selectin-PSGL-1 interaction resulted in platelet phagocytosis in vitro and influenced the ability of MPs to elicit NETs, endothelial activation, and migration of leukocytes through the pulmonary microvasculature. CONCLUSION: The clearance of activated platelets via PSGL-1 limits the undesirable effects of MP-elicited neutrophil activation. This balance is disrupted in patients with SSc. Its reconstitution might curb vascular inflammation and prevent fibrosis.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Manfredi AA, Ramirez GA, Godino C, et al. Platelet Phagocytosis via P-selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis. Arthritis Rheumatol. 2021. PMID: 34279048. doi:10.1002/art.41926

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。